logo
logo

Alfasigma Completes Acquisition Of Intercept Pharmaceuticals, Inc.

Alfasigma Completes Acquisition Of Intercept Pharmaceuticals, Inc.

11/08/23, 2:17 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/IT.svgbologna
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgmorristown
Industry
biotechnology
health care
manufacturing
Alfasigma S.p.A. (“Alfasigma”) and Intercept Pharmaceuticals, Inc. (“Intercept”) announced today the completion of the acquisition of Intercept by Alfasigma through its wholly owned subsidiary Interstellar Acquisition Inc.

Company Info

Company
ALFASIGMA
Location
Bologna, Emilia Romagna, Italy
Company info
Alfasigma is one of Italy's leading pharmaceutical companies with a strong international position. The Group has a worldwide presence in over 100 countries where about 3000 people work in research, development, production and distribution. In Italy, Alfasigma is a leader in the prescription products market where, in addition to its strong focus on gastro-intestinal products, it is present in several primary care therapeutic areas. It is popular with the consumer public for a number of nutraceuticals & food supplements that respond to different needs, and that are well known and deeply rooted in the Italian families experience. Its historical headquarters is in Bologna, to which is added Milan, while the production sites are: in Italy, in Pomezia (RM), Alanno (PE), Sermoneta (LT) and Trezzano Rosa (MI) and abroad in Tortosa in Spain and in Shreveport (Louisiana) in the United States. The R&D laboratories are in Pomezia and in the Parco Scientifico Tecnologico Kilometro Rosso in Bergamo. Alfasigma's mission is to improve people's health and quality of life by offering caregivers and healthcare personnel therapeutic solutions according to the highest standards of quality and safety.